Ghildyal P, Palani D, Manchanda R
Biomedical Engineering Group, School of Biosciences and Bioengineering, Indian Institute of Technology--Bombay, Mumbai 400076, India.
J Physiol. 2006 Sep 1;575(Pt 2):469-80. doi: 10.1113/jphysiol.2006.109678. Epub 2006 May 4.
At sites of purinergic neurotransmission, synaptic ecto-ATPase is believed to limit the actions of ATP following its neural release. However, details of the modulation by this enzyme of the ATP-mediated conductance change and the possible mechanisms mediating this modulation remain unelucidated. We have addressed these issues by studying the effect of ARL 67156, a selective ecto-ATPase inhibitor, on ATP-mediated electrical and contractile activity in the sympathetically innervated guinea-pig vas deferens. ARL 67156 at 100 mum significantly potentiated the amplitude of spontaneous excitatory junction potentials (SEJPs) by 81.1% (P < 0.01) and prolonged their time courses (rise time by 49.7%, decay time constant by 38.2%; P < 0.01). Moreover, the frequency of occurrence of SEJPs was strikingly increased (from 0.28 +/- 0.13 to 0.90 +/- 0.26 Hz; P < 0.01), indicating an additional, primarily presynaptic, effect of ecto-ATPase inhibition. The frequency of occurrence of discrete events (DEs), which represent nerve stimulation-evoked quantal release of neurotransmitter, was also increased ( approximately 6-fold; P < 0.01), along with the appearance of DEs at previously 'silent' latencies. Purinergic contractions of the vas deferens were potentiated significantly (P < 0.01) by ARL 67156; these potentiated contractions were suppressed by the A1 agonist adenosine (P < 0.01) but left unaffected by the A1 antagonist 8-phenyltheophylline (8-PT). Our results indicate (i) that ecto-ATPase activity, in addition to modulating the ATP-mediated postjunctional conductance change, may regulate transmitter release prejunctionally under physiological conditions, and (ii) that the prejunctional regulation may be mediated primarily via presynaptic P2X, rather than A1, receptors.
在嘌呤能神经传递部位,人们认为突触外ATP酶在ATP从神经释放后会限制其作用。然而,关于该酶对ATP介导的电导变化的调节细节以及介导这种调节的可能机制仍未阐明。我们通过研究选择性外ATP酶抑制剂ARL 67156对交感神经支配的豚鼠输精管中ATP介导的电活动和收缩活动的影响来解决这些问题。100 μmol的ARL 67156显著增强了自发性兴奋性接头电位(SEJPs)的幅度,增幅达81.1%(P < 0.01),并延长了其时间进程(上升时间增加49.7%,衰减时间常数增加38.2%;P < 0.01)。此外,SEJPs的发生频率显著增加(从0.28±0.13 Hz增至0.90±0.26 Hz;P < 0.01),表明外ATP酶抑制具有额外的、主要是突触前的效应。代表神经刺激诱发的神经递质量子释放的离散事件(DEs)的发生频率也增加了(约6倍;P < 0.01),同时在先前“沉默”的潜伏期出现了DEs。ARL 67156显著增强了输精管的嘌呤能收缩(P < 0.01);这些增强的收缩被A1激动剂腺苷抑制(P < 0.01),但不受A1拮抗剂8 - 苯基茶碱(8 - PT)的影响。我们的结果表明:(i)外ATP酶活性除了调节ATP介导的接头后电导变化外,在生理条件下可能还会在突触前调节递质释放;(ii)突触前调节可能主要通过突触前P2X受体而非A1受体介导。